Allergy medicine and thyroid medication can interact in ways that affect treatment safety and effectiveness. For the millions of people in the UK managing hypothyroidism or hyperthyroidism — typically with levothyroxine or carbimazole — choosing the right allergy remedy requires careful thought. Certain antihistamines, decongestants, and combination products can interfere with thyroid hormone absorption, worsen cardiovascular symptoms, or mask signs of poor thyroid control. This article explains the key interactions, which allergy treatments are safer to use, and when to seek advice from your GP or pharmacist.

How Allergy Medicines Can Interact With Thyroid Medication

Allergy medicines can interfere with levothyroxine absorption or worsen cardiovascular symptoms, particularly oral decongestants, which stimulate adrenergic receptors and are contraindicated in uncontrolled hyperthyroidism.

For people managing a thyroid condition — whether hypothyroidism treated with levothyroxine or hyperthyroidism managed with carbimazole — taking allergy medicines alongside thyroid medication requires careful consideration. Drug interactions can affect how thyroid medications are absorbed, metabolised, or excreted, potentially altering their effectiveness and leading to either under- or over-treatment of the underlying thyroid condition.

Worried about interactions with other medications? Speak to one of our pharmacists →

Levothyroxine, the most commonly prescribed thyroid hormone replacement in the UK, is particularly sensitive to absorption interference. It should be taken on an empty stomach, ideally at least 30 minutes before food and other medicines. A number of substances can bind to levothyroxine in the gut and reduce the amount that enters the bloodstream. These include antacids and mineral supplements containing calcium carbonate, aluminium hydroxide, or magnesium salts, as well as iron salts, cholestyramine, sucralfate, and orlistat. These are not typical allergy remedies, but patients who take such products alongside allergy treatments should be aware of the need to separate them from levothyroxine by at least four hours.

Beyond absorption, some allergy medicines can influence the autonomic nervous system or cardiovascular function in ways that overlap with thyroid hormone activity. This is particularly relevant for oral decongestants such as pseudoephedrine and phenylephrine, which stimulate adrenergic receptors and can exacerbate symptoms such as palpitations or elevated heart rate — symptoms that are already common in people with poorly controlled hyperthyroidism. These agents are contraindicated or should be used with great caution in patients with hyperthyroidism, severe hypertension, coronary artery disease, or those taking monoamine oxidase inhibitors (MAOIs), in line with their Summary of Product Characteristics (SmPC). Understanding these interactions is the first step in managing both conditions safely.

Patients and healthcare professionals are encouraged to report suspected adverse drug reactions — including unexpected interactions between allergy medicines and thyroid treatments — via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk or via the MHRA Yellow Card app.

Common Allergy Treatments and Their Effects on Thyroid Function

Second-generation antihistamines have minimal impact on thyroid function, while oral decongestants carry the greatest risk, particularly in hyperthyroidism; intranasal corticosteroids are generally safe at standard doses.

The most widely used allergy treatments in the UK fall into several categories: antihistamines, intranasal corticosteroids, decongestants, and leukotriene receptor antagonists. Each carries a different risk profile when used alongside thyroid medication.

Antihistamines (such as cetirizine, loratadine, and chlorphenamine) are generally considered to have a low direct impact on thyroid hormone levels. However, older, sedating antihistamines such as chlorphenamine have anticholinergic properties that can worsen symptoms such as constipation, dry mouth, and urinary retention — symptoms that may already be present in people with hypothyroidism — and should therefore be used with caution in this group.

Not sure if this is normal? Chat with one of our pharmacists →

Decongestants, particularly those containing pseudoephedrine or phenylephrine, are of greater concern. These sympathomimetic agents stimulate the sympathetic nervous system and can raise blood pressure and heart rate. In patients with hyperthyroidism, or those whose levothyroxine dose is slightly too high, this can compound cardiovascular symptoms. Importantly, the MHRA issued a safety update in 2024 highlighting that oral pseudoephedrine carries a risk of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS). Patients should stop taking pseudoephedrine and seek urgent medical attention if they develop a sudden or severe headache, confusion, seizures, or visual disturbances.

Intranasal decongestants (such as xylometazoline nasal sprays) may be considered as a short-term alternative to oral sympathomimetics, as systemic absorption is lower; however, use should be limited to five to seven days, and caution is still advised in patients with hyperthyroidism.

Intranasal corticosteroids (such as fluticasone or beclometasone nasal sprays) are recommended by NICE CKS as first-line treatment for allergic rhinitis and are generally considered safe for people with thyroid conditions when used as directed. Systemic absorption is minimal at standard doses.

Montelukast, used for allergic asthma and rhinitis, does not appear to significantly interact with thyroid medications. However, the MHRA has issued guidance on the risk of neuropsychiatric reactions with montelukast — including sleep disturbances, mood changes, and suicidal ideation. Patients should seek medical advice promptly if such symptoms occur. All patients should disclose their full medication list to their prescriber or pharmacist.

Which Antihistamines and Decongestants Are Safer to Use

Cetirizine, loratadine, and fexofenadine are the preferred antihistamines for people on thyroid medication; oral decongestants should be avoided in hyperthyroidism, with intranasal corticosteroids or saline rinses used instead.

When selecting an allergy medicine alongside thyroid medication, the choice of agent matters. In general, second-generation, non-sedating antihistamines are preferred for most patients with thyroid conditions due to their more favourable side-effect profile.

Preferred options include:

• Cetirizine (e.g., Piriteze, Zirtek) — widely available over the counter, non-sedating, and with minimal cardiovascular effects

• Loratadine (e.g., Clarityn) — similarly well tolerated and less likely to cause sedation or anticholinergic effects

• Fexofenadine — another non-sedating option, available on prescription, with a good safety profile

It is worth noting that even second-generation antihistamines can cause drowsiness in some individuals; patients should exercise caution when driving or operating machinery until they know how a medicine affects them.

These antihistamines do not appear to significantly affect thyroid hormone levels or interfere with levothyroxine absorption when taken at appropriate times.

In contrast, oral decongestants should be used with caution or avoided, particularly in patients with hyperthyroidism, severe hypertension, coronary artery disease, or arrhythmias, and must not be used with MAOIs. Pseudoephedrine-containing products (such as some formulations of Sudafed) are best avoided in those with uncontrolled hyperthyroidism or significant cardiovascular disease. If nasal congestion is a significant problem, intranasal corticosteroid sprays or saline nasal rinses are safer first-line alternatives. Short-term use of intranasal decongestants (for no more than five to seven days) may be considered where necessary, though caution remains appropriate in hyperthyroidism.

Combination allergy products — those containing both an antihistamine and a decongestant — should be approached with particular care. Always check the full ingredient list before purchasing any over-the-counter remedy, and if in doubt, consult a pharmacist who can review your current thyroid medication and advise accordingly.

Managing Allergies When You Have a Thyroid Condition

Non-pharmacological measures such as saline nasal irrigation and allergen avoidance reduce interaction risk; when medication is needed, intranasal corticosteroids are first-line and levothyroxine timing should be maintained.

Living with both a thyroid condition and allergies requires a structured approach to symptom management that minimises the risk of drug interactions and avoids destabilising thyroid hormone levels. Fortunately, many effective allergy management strategies are non-pharmacological and carry no interaction risk.

Non-pharmacological measures that can help reduce allergy burden include:

• Monitoring local pollen counts and limiting outdoor exposure during high-pollen periods

• Using allergen-proof mattress and pillow covers to reduce house dust mite exposure

• Keeping windows closed during peak pollen seasons

• Regular nasal saline irrigation to clear allergens from the nasal passages

When medication is necessary, timing is important — particularly for those taking levothyroxine. Levothyroxine should be taken on an empty stomach, at least 30 minutes before food and other medicines. Antacids, calcium supplements, iron preparations, and aluminium- or magnesium-containing products should be separated from levothyroxine by at least four hours. If an antihistamine is needed, taking it at a different time of day (for example, in the evening) is a practical approach, even though the interaction risk with most antihistamines is considered low.

For patients with allergic rhinitis, NICE CKS guidance and BSACI recommendations support intranasal corticosteroids as the most effective first-line treatment, and these remain appropriate for people with thyroid conditions. Allergen immunotherapy (desensitisation) may also be considered in specialist settings for those with severe, persistent allergic rhinitis, and does not contraindicate thyroid medication use.

Regular thyroid function monitoring via TSH blood tests remains essential. In line with NICE NG145, TSH should be checked six to eight weeks after any dose change or introduction of an interacting medicine, and then at six- to twelve-monthly intervals once stable. Monitoring should be more frequent during pregnancy, as thyroid hormone requirements may change significantly.

When to Seek Advice From Your GP or Pharmacist

Seek urgent medical attention for sudden severe headache, chest pain, or confusion after taking a decongestant; contact your GP or pharmacist if new allergy medicines cause palpitations, mood changes, or worsening thyroid symptoms.

Knowing when to seek professional guidance is an important aspect of safe self-management. While many allergy medicines are available without a prescription, this does not mean they are automatically suitable for everyone — particularly those on long-term thyroid medication.

Call 999 or go to your nearest A&E immediately if you experience:

• Severe chest pain, severe breathlessness, or fainting

• A sudden or severe headache, confusion, seizures, or visual disturbances — particularly after taking a decongestant (these may be signs of PRES or RCVS)

If you are taking carbimazole, stop the medicine and seek same-day urgent medical assessment — including a full blood count — if you develop a fever, sore throat, or mouth ulcers. These may be signs of agranulocytosis, a rare but serious reduction in white blood cells that requires prompt investigation, as highlighted in the carbimazole SmPC and MHRA guidance.

Contact your GP or pharmacist if you experience any of the following:

• Palpitations, rapid or irregular heartbeat, or chest discomfort after starting a new allergy medicine

• Worsening fatigue, weight changes, or mood disturbance that could suggest a change in thyroid control

• Difficulty sleeping, increased anxiety, or tremor — symptoms that may indicate over-replacement with levothyroxine, potentially exacerbated by stimulant-containing allergy products

• Mood changes, sleep disturbances, or other neuropsychiatric symptoms after starting montelukast

• Persistent or worsening allergy symptoms that are not responding to standard over-the-counter treatments

You should also seek advice before starting any new allergy medicine if you are pregnant and have a thyroid condition, as both thyroid hormone requirements and allergy management strategies may need to be adjusted during pregnancy. Similarly, patients with cardiovascular disease or arrhythmias should consult a healthcare professional before using any decongestant-containing product.

Pharmacists are an excellent first point of contact for medication queries and can review your full medication list — including levothyroxine or carbimazole — to identify any potential interactions before you purchase an over-the-counter product. If your allergy symptoms are significantly affecting your quality of life or are difficult to control, your GP may refer you to an allergy specialist or an endocrinologist, depending on the complexity of your thyroid condition.

MHRA and NICE Guidance on Thyroid Medication Safety

The MHRA advises consistent levothyroxine use and separation from interacting substances by four hours; NICE NG145 recommends TSH monitoring six to eight weeks after any medication change.

The Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE) both provide important guidance relevant to the safe use of thyroid medications alongside other treatments, including allergy medicines.

The MHRA has issued advice regarding levothyroxine (Drug Safety Update, June 2021), noting that its absorption can be affected by a range of substances, including certain foods, supplements, and medications. The MHRA recommends that patients are counselled to take levothyroxine consistently — ideally at the same time each day, on an empty stomach, at least 30 minutes before food — and to separate it from calcium- or iron-containing products, antacids, and aluminium- or magnesium-containing preparations by at least four hours. Patients should inform their prescriber of any new medicines, including over-the-counter products.

Regarding levothyroxine brand switching, the MHRA 2021 Drug Safety Update advises that patients should aim to use a consistent product. If a patient develops symptoms after switching to a different brand or formulation, clinicians should consider returning them to their previous product and checking thyroid function. Patients should not switch between brands without medical supervision.

The MHRA issued a further safety update in 2024 on pseudoephedrine, highlighting the risk of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS). Patients taking pseudoephedrine who develop a sudden or severe headache, confusion, seizures, or visual disturbances should stop the medicine immediately and seek urgent medical attention.

NICE guidance on thyroid disease (NG145) emphasises the importance of regular TSH monitoring and highlights that dose adjustments may be needed if a patient's medication regimen changes. NICE CKS guidance on allergic rhinitis, alongside BSACI rhinitis guidelines, supports the use of intranasal corticosteroids as first-line treatment — an approach that aligns well with the safety requirements of patients on thyroid medication.

Patients are encouraged to:

• Always inform their GP, pharmacist, or specialist of all medicines they are taking, including over-the-counter and herbal products

• Maintain a consistent levothyroxine product and seek medical advice before switching formulations

• Attend regular blood tests to monitor thyroid function, especially when introducing new medications

• Report any suspected side effects or unexpected interactions via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk or via the MHRA Yellow Card app

Overall, with appropriate awareness and professional guidance, people with thyroid conditions can manage their allergies safely and effectively.

Frequently Asked Questions